Sanjay Mohan: Clinical Trials

2 trials sponsored by Sanjay Mohan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Terminated 1

Follow Sanjay Mohan: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant
Venetoclax, Decitabine, Cedazuridine - Recurrent Acute Myeloid Leukemia
Phase 2TerminatedSanjay Mohan12023-04-132026-01-09
Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies
Venetoclax, Selinexor - Diffuse Large B-cell Lymphoma, Acute Myeloid Leukemia
Phase 1CompletedSanjay Mohan782019-06-212026-10-29

Conditions studied

Leukemia, Myeloid, Acute (2)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)

Interventions

venetoclax (2)  ·  Biopsy (1)  ·  Decitabine (1)  ·  cedazuridine (1)  ·  selinexor (1)

Countries

United States (2)

Results publications

PMID 41796974